April 03, 2025

Study Reveals Psychiatric Sequelae Post-COVID-19

COVID-19 survivors showed a significantly higher risk of psychiatric disorders, according to a recent study.

Conexiant

April 02, 2025

Donanemab: Amyloid-Related Imaging Abnormalities

"ARIA is an adverse event associated with donanemab treatment that requires safety monitoring."

Conexiant

April 02, 2025

New Antibody Lowers COVID-19 Cases in Trial

Sipavibart reduced symptomatic COVID-19 by 34.9% compared to standard treatment, but efficacy was only observed against non–Phe456Leu-containing variants, according to new phase 3 trial data.

Conexiant

April 02, 2025

Do NSAIDs Prevent Dementia?

Long-term anti-inflammatory use linked to 12% reduced dementia risk in 14-year population study.

Conexiant

April 02, 2025

From Refugee to Resident

How Sophia Bellegarde overcame the odds to become a pathologist

The Pathologist

April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant

April 01, 2025

Coding: Reimbursement for OCT Angiography

The 2025, CPT Handbook contains a new procedure code for reporting OCT angiography (OCTA). This is a welcome addition to the list of codes for retinal scanning diagnostic services.

Ophthalmic Professional

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 31, 2025

Cold Plunges: A Cellular Reset?

New research shows that 1 week of daily cold-water immersion enhances autophagy and reduces cell death signals.

Conexiant